Noninvasive blood glucose assay using a newly developed near-infrared system

This paper reports in vivo near-infrared (NIR) noninvasive blood glucose assay using dermis tissue spectra. We assume that the glucose content in dermis tissue traces the variations in blood glucose. For dermis spectra measurements, epidermis, especially stratum corneum, acts as an interference in skin tissue. Thus, we have developed a method for the selective measurement of dermis tissue spectra, enabling us to obtain better quality spectra for an accurate blood glucose assay. The selective measurement of the dermis spectra realized by using a newly developed fiber-optic probe that consists of source and detector optical fibers separated by 0.65 mm on a skin surface. The light path in the skin tissue for this geometry has been simulated by a Monte Carlo method. The simulation results show that detected light mainly interrogates dermis tissue. As the absorbance signal of glucose in human tissue is extremely small, the quality of the measured spectra is critical for the reliable assay. The present method for blood glucose assay has been applied to one Type 1 diabetic. The correlation coefficient between the blood glucose content predicted by NIR spectra and those measured by finger-prick was 0.928 and the standard error of prediction was 32.2 mg/dL. These results demonstrate the potential of our methodology for noninvasive NIR blood glucose assay.